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Abstract 
Background: To prevent malaria infection during pregnancy in endemic areas in Africa, the World Health Organiza-
tion recommends the administration of intermittent preventive treatment in pregnancy (IPTp) as part of the focused 
antenatal care package. However, IPTp uptake in most countries remains low despite generally high antenatal care 
coverage and increased efforts by governments to address known bottlenecks such as drug stock-outs. The study 
explored factors that continue to impede uptake of IPTp among women who attend antenatal care. This paper 
focuses on demand-side barriers with regard to accessibility, affordability and acceptability.
Methods: The research was conducted in 2013/2014 and involved 46 in-depth interviews with four types of 
respondents: (i) seven district health officials; (ii) 15 health workers; (iii) 19 women who attended antenatal care; (iv) 
five opinion leaders. Interviews were conducted in Eastern and West Nile regions of Uganda. Data was analysed by 
thematic analysis.
Results: District health officials and health workers cited a range of barriers relating to knowledge and attitudes 
among pregnant women, including lack of awareness of pregnancy-related health risks, a tendency to initiate ante-
natal care late, reluctance to take medication and concerns about side effects of IPTp. However, women and opinion 
leaders expressed very positive views of antenatal care and IPTp. They also reported that the burden of travel and 
cost associated with antenatal care attendance was challenging, but did not keep them from accessing a service they 
perceived as beneficial. The role of trust in health workers’ expertise was highlighted by all respondents and it was 
reported that women will typically accept IPTp if encouraged by a health worker.
Conclusions: Given the positive views of antenatal care and IPTp, high antenatal care coverage and reported low 
refusal rates for IPTp, supply-side issues are likely to account for the majority of missed opportunities for the provision 
of IPTp when women attend antenatal care. However, to increase uptake of IPTp on the demand side, health workers 
should be encouraged to reassure eligible women that IPTp is safe.
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Background
Pregnant women are more susceptible to malaria infec-
tion than non-pregnant women and have a higher risk of 
suffering from severe disease. In areas of high and stable 
malaria transmission, where women have acquired high 
levels of immunity, malaria infection during pregnancy is 
often asymptomatic, but can still have devastating con-
sequences for both mother and child, including maternal 
anaemia, stillbirth, and low birth weight, a major risk fac-
tor for infant mortality and morbidity [1, 2].
Preventing and controlling malaria infection during 
pregnancy is therefore an important strategy to improve 
maternal and newborn health. In areas of high and mod-
erate transmission in Africa, the World Health Organiza-
tion (WHO) recommends a three-pronged approach [3]:
1. Effective case management for malaria illness and 
anaemia during pregnancy;
2. The use of insecticide-treated nets by pregnant 
women;
3. Intermittent preventive treatment in pregnancy 
(IPTp), which involves repeated administration of 
curative doses of a safe and effective anti-malarial 
to pregnant women, without testing the recipient’s 
infection status. The drug used for IPTp is called 
sulfadoxine-pyrimethamine (SP) and is also known 
under its brand name Fansidar®. Pregnant women 
typically receive IPTp as part of the focused antena-
tal care (ANC) package, which specifies that preg-
nant women should have at least four assessments 
at specified intervals by or under the supervision of 
a skilled attendant [4]. WHO currently recommends 
IPTp at each ANC visit after the first trimester, with 
doses given at least 1 month apart [5]. IPTp should be 
administered as directly observed therapy (DOT).
Even though ANC coverage in African countries is 
generally high, many countries have struggled to achieve 
high levels of uptake of IPTp [6], which suggests that 
opportunities for the provision of IPTp during ANC are 
being missed. It should be noted, however, that there are 
a number of complicating factors:
  • Not all pregnant women attending ANC are eligible 
for IPTp. It should not be provided to women in the 
first trimester or to women who are human immuno-
deficiency virus (HIV) positive and taking co-trimox-
azole prophylaxis.
  • Women do not necessarily follow the recommended 
four-visit ANC schedule. If they initiate ANC late 
during their pregnancy or visit infrequently, there 
will be limited opportunities for provision of sub-
sequent doses of IPTp. Attendance for the third or 
fourth visit is typically much lower than the first and 
second visit.
Governments and implementing partners in many 
countries have stepped up efforts to increase uptake of 
IPTp, addressing some of the known bottlenecks, such as 
stock-outs of drugs and commodities at ANC clinics and 
lack of guidance and supervision for health workers [7, 
8]. However, IPTp coverage remains low in many coun-
tries where malaria is endemic [9].
While there is a growing body of quantitative data 
exploring barriers to and determinants of IPTp uptake, 
comparatively few studies have sought to approach the 
issue from a qualitative point of view [7, 10]. There is 
hence limited understanding of the barriers that con-
tinue to impede IPTp despite high ANC attendance and 
increased attention on the part of governments and 
implementing partners. This study explored thoughts 
and opinions of key stakeholders (district health officials, 
health workers, pregnant women and mothers, opinion 
leaders) to better understand how stakeholders’ percep-
tions may affect uptake of IPTp, particularly for those 
women who attend ANC, albeit not necessarily following 
the recommended four-visit schedule. The study there-
fore sought to address two research questions:
1. What are the barriers to women receiving or taking 
IPTp during ANC?
2. What are the barriers to women initiating ANC early 
and attending repeatedly?
The study was conducted with the aim of inform-
ing the development of an intervention that could help 
increase uptake of IPTp for women attending ANC. 
Given the volume of data collected and large number of 
topics explored, data relating to demand and supply-side 
issues are presented in separate papers. While acknowl-
edging that supply and demand side are inevitably inter-
connected and that under programmatic conditions it is 
typically necessary to address both sides concurrently, 
the authors nevertheless found applying an analyti-
cal framework which uses this distinction as its starting 
point useful in exploring the multitude of factors affect-
ing utilization of health services [11]. This paper presents 
data relating to demand-side barriers, specifically chal-
lenges relating to accessibility, affordability and accepta-
bility of ANC and IPTp. Note that this includes data from 
respondents representing both the supply (health work-
ers, health officials) and the demand side (women, opin-
ion leaders). Results relating to supply-side issues have 
been published elsewhere [12].
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Methods
Study design
The study was a cross-sectional qualitative study, which 
involved a total of 46 in-depth interviews with four types 
of respondents: district health officials, health workers, 
women who had attended ANC and opinion leaders (for 
example traditional birth attendants, local councillors 
and teachers). Sample size and approach were deter-
mined taking into account available time and budget to 
allow for a thorough, in-depth exploration of the research 
questions from the point of view of a range of key 
informants. Reporting of the study methods and results 
follows the consolidated criteria for reporting qualitative 
research (COREQ) [13]. The study also included a docu-
ment and record review at four health facilities. However, 
as the findings from this review relate exclusively to sup-
ply-side barriers, they are not reported in this paper.
Study setting
IPTp and ANC in Uganda
In Uganda, country-wide implementation of IPTp with 
SP started in 2001. According to the most recent house-
hold survey data available at the time of the research, 
only a quarter of women received at least two doses of 
IPTp in 2011, while 90% attended ANC at least twice and 
48% followed the recommended schedule of four ANC 
visits. The median month of gestation at which women 
initiated ANC was 5.1 [14]. According to the latest avail-
able household survey data at the time of publication, 
uptake of two or more doses of IPTp had increased to 
45% in 2014/15 [15].
At the time of data collection, the country had not 
yet adopted the latest WHO policy recommendation 
of monthly administration of SP. The different policy 
documents and guidelines governing IPTp provision at 
the time were “inconsistent or unclear” [16], but gener-
ally suggested that women should receive a maximum of 
two doses of SP during the course of a pregnancy. IPTp 
is provided as part of the ANC package at health centres 
II, III, IV and hospitals. ANC services should be provided 
free-of-charge to women accessing ANC through public 
health facilities.
Study regions, districts and health facilities
The study was conducted in two regions of Uganda: East-
ern and West Nile (see Fig. 1). Eastern region has histori-
cally received high levels of support from implementing 
partners and has consistently been among the regions 
reporting higher than average IPTp uptake. West Nile, 
on the other hand, has received less investment and typi-
cally reports IPTp uptake levels below the national aver-
age. According to the most recent household survey 
data available at the time of the research, 33 and 21% 
of women in Eastern and West Nile regions received 
two doses of IPTp respectively in 2011. In 2014/15, this 
figure was 36% for Eastern and 35% for West Nile [15]. 
Table 1 presents ANC and IPTp uptake data from Ugan-
da’s Health Management Information System (HMIS) for 
the four study districts compared with the national and 
regional average for the 2 years preceding data collec-
tion (2011–2012). Note that the regional uptake patterns 
found by household surveys are not consistently reflected 
in the HMIS data, which are compiled from health facil-
ity reports. The HMIS data was extracted for this publi-
cation and not available to the study team at the time of 
selecting the study regions and districts.
Within each region, the study team selected one rural 
and one urban district based on convenience. Two health 
facilities were selected in each district, again by conveni-
ence sampling, but taking care to include the different 
levels of health facilities involved in providing ANC, as 
well as public and private not-for-profit (PNFP) provid-
ers. Private for-profit facilities were excluded from the 
sample as the Ministry of Health in Uganda does not 
provide specific support on IPTp to this type of facility. 
Figure  2 shows the types and levels of health facilities 
sampled in each study district.
Participant selection
District health officials
Two district health officials were purposively selected in 
each of the four study districts with the help of the Dis-
trict Health Officer. The selection was based on their 
involvement in malaria or maternal health program-
ming, as well as health supervision. In one district, only 
one suitable interviewee was available on the day of the 
research team’s visit, so a total of seven interviews with 
district health officials were conducted. These included 
three Malaria Focal Persons, one Assistant District 
Health Officer in charge of maternal and child health, 
one Health Educator, one Stores Assistant and one HMIS 
Focal Person.
Health workers
Two health workers involved in the provision of ANC or 
supervision of ANC services were purposively identified 
at each of the eight health facilities with the help of the 
facility in-charge. At one facility only one suitable inter-
viewee was available on the day of the research team’s 
visit, so a total of 15 interviews with health workers were 
conducted—seven with the most senior member of staff 
present and eight with midwives.
Women
At each of the eight health facilities, two women who had 
accessed ANC and lived within the catchment area were 
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identified with assistance from health workers. Generally, 
one of the women selected was pregnant at the time of 
the interview, while the other had given birth during the 
previous 12 months. Similarly, where possible, the team 
selected one woman who lived within walking distance 
from the facility and one woman from the fringes of the 
facility’s catchment area, in order to determine whether 
distance from the facility affected her perceptions of 
IPTp. However, it proved difficult to apply distance from 
the health facility as a sampling criterion and relevant 
information was not consistently captured in the field.
The initial analysis of data collected from these 16 
women using health workers as gatekeepers showed that 
all women had received a full course of IPTp and had 
generally positive views of ANC and IPTp. The research 
team felt that additional data should be collected from 
women who had not received a full course of IPTp, 
defined as at least two doses as per national guidelines at 
the time. A second round of data collection was therefore 
conducted, where women were identified from facilities’ 
ANC registers without involvement from health workers. 
A total of 12 women who, according to the register, had 
not received IPTp when they visited ANC, were identi-
fied. However, only three additional interviews were con-
ducted (all with women who had recently given birth). 
The remaining nine women identified indicated that they 
had in fact received IPTp at that visit, and it had there-
fore been incorrectly recorded in the register, or they 
Fig. 1 Map of the Republic of Uganda. Study regions highlighted in dark grey
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had been informed that they were not eligible for IPTp 
when they visited ANC, so had correctly not received it. 
Two of the three women interviewed in round two stated 
that they had received one dose of IPTp at a previous 
visit. A total of 19 women were interviewed during two 
rounds of data collection. Though the sample size is not 
large enough to draw valid conclusions with regard to the 
accuracy of uptake figures, the research team’s difficul-
ties in finding women who had not received a full course 
of IPTp may suggest higher than expected uptake com-
pared with those reported through household surveys or 
HMIS. Data accuracy has been highlighted as a challenge 
to effective monitoring and evaluation of malaria inter-
ventions by the Government of Uganda [17], a conclu-
sion which is also supported by supply-side findings from 
this study [12].
Opinion leaders
To test the largely positive views expressed by women 
about IPTp and ANC during the first round of data 
collection, five opinion leaders who were considered 
influential in shaping communities’ perceptions of mater-
nal and child health were identified with the help of the 
sub-county Secretary for Health. This included two tra-
ditional birth attendants, one community councillor, one 
teacher and one retired midwife.
Data collection
Field work and researcher training
CR and eight local field researchers (five female, three 
male) conducted the first round of data collection in 
November 2013. All field researchers had relevant 
language skills and were university or college gradu-
ates with previous experience of mainly quantitative 
field research. Prior to conducting the field work, they 
attended a five-day training conducted by CR, which 
covered the study design, information on malaria in 
pregnancy and IPTp, as well as qualitative research 
techniques and best practice. The second round of data 
collection was conducted in April/May 2014 by CR and 
three of the field researchers (one female, two male) 
who had been involved in the first round of data collec-
tion. Field researchers involved in round two received 
a 1-day refresher training conducted by CR. Interviews 
generally lasted between 45 and 75  min. While in the 
field, researchers had daily briefings with CR to discuss 
and resolve challenges.
Interview guides
Guides for semi-structured interviews with district 
health officials, health workers and women were devel-
oped in English by CR, KG, RK and SGS before the first 
round of data collection (see Additional files 1, 2, 3). 
The interview guide for opinion leaders was developed 
by CR and KG before the second round of data collec-
tion (see Additional file  4). Interview topics explored 
were based on a framework of themes derived from a 
Table 1 Antenatal care and IPTp uptake data (%) in study districts, 2011–2012 (Source: Health Management Information 
System, Republic of Uganda)
a ANC1: First antenatal care visit; denominator: expected pregnancies (5% of total population in the area)
b ANC4: fourth antenatal care visit; denominator: expected pregnancies (5% of total population in the area)
c IPT1: first dose of IPTp; denominator: ANC1
d IPT2: second dose of IPTp; denominator: ANC1
ANC1a ANC4b IPT1c IPT2d
2011 2012 2011 2012 2011 2012 2011 2012
Uganda 90 84 29 28 58 79 44 50
Eastern 73 67 18 18 79 83 51 52
Urban study district 57 66 15 29 97 96 70 76
Rural study district 43 61 6 9 78 93 66 55
West Nile 46 57 18 22 83 86 59 62
Urban study district 61 101 19 36 76 81 50 54
Rural study district 20 22 13 11 92 92 71 69
Fig. 2 Types of health facilities sampled. HC health centre, PNFP 
private not-for-profit
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review of the literature on barriers to IPTp uptake, as 
well as authors’ experience of implementing malaria in 
pregnancy interventions. See Table  2 for an overview 
of topics relating to demand-side issues explored in 
the interview guides by type of respondent. All inter-
view guides included open-ended general questions 
about interviewees’ perceptions of IPTp and the rea-
sons behind the low uptake of the service. This enabled 
respondents to also bring up topics not specifically cov-
ered by the interview guides.
Interview guides were discussed in detail during the 
researcher training. The interview guide for women was 
translated into the local languages spoken in the study 
districts (Ateso, Lugbara and Madi) by researchers who 
were native speakers of those languages. Accuracy of the 
translation was checked by field researchers with native 
language skills in the respective languages during the 
training preceding the field work. The interview guides 
for district health officials, health workers and women 
were subsequently pre-tested with relevant participants 
from a district that was not included in the study. As the 
interview guide for opinion leaders was based on ques-
tions used with other types of respondents, pre-test-
ing was not considered necessary. Table  3 provides an 
overview of the number of interviews conducted, how 
interviewees were approached, where interviews were 
conducted and which language was used with the differ-
ent types of respondents.
Transcription and translation
All interviews were audio-recorded. Those conducted in 
English were transcribed verbatim and those conducted 
in a local language were translated and transcribed in 
English directly from the recording. All were transcribed 
by the researcher who had conducted the interview. Field 
researchers were required to take notes during the inter-
view and to include contextual information (e.g. non-ver-
bal clues) in the transcripts.
Data analysis
Interview transcripts were managed using NVivo 10 
(QSR International) qualitative analysis software. The-
matic analysis, using a combination of deductive and 
inductive approaches, was carried out by CR, KG and 
RK, who agreed an initial coding frame based on the 
framework used for the development of interview guides 
and analysis of a sample of five transcripts. All transcripts 
were coded by CR who discussed and agreed subsequent 
changes to the coding frame with KG and RK, taking 
into account emerging themes. The headings used in the 
results and discussion section of this paper reflect the 
main codes used for the analysis of demand-side issues.
Results and discussion
Demand-side barriers to IPTp uptake will be discussed 
under the themes of accessibility, affordability and 
acceptability.
Table 2 Demand-side topics covered by interview guides by type of respondent
X denotes that this topic was covered by a specific question or probe in the interview guide
Topic District health officials Health workers Women Opinion leaders
Burden of travel – – X –
User fees – X X –
Indirect costs – – X –
Vulnerability and social support – – X X
Formal vs. traditional care – – X –
Malaria and malaria prevention – – X X
Timing and frequency of ANC attendance – X X –
Attitudes towards ANC – – X X
Attitudes towards IPTp and SP – X X X
Table 3 Number of interviews conducted, approach, location and language used by type of respondent
District health officials Health workers Women Opinion leaders
No of interviews 7 15 19 5
Approach By District Health Officer about 
1 week before the research-
ers’ visit to the district
Facility in-charge about 1 week 
before the researchers’ visit to 
the health facility
By researchers on the day of 
the interview
By researchers on the day of the 
interview
Location District health office Respondent’s place of work Respondent’s home Respondent’s home
Language English English Local language English
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Accessibility
District health officials and health workers often specu-
lated that living at a distance from the nearest health 
facility and the effort required in travelling to the point of 
care kept some pregnant women from accessing ANC or 
from attending ANC early and consistently. Several of the 
women interviewed who lived in more remote communi-
ties confirmed that travelling to ANC, and in particular 
having to walk or ride on motorcycles for long distances 
and along poor roads, was burdensome:
Woman 5: If your body becomes too heavy, walking 
also becomes difficult if there is nobody to bring you.
The statement may also reflect a reluctance to travel 
far during the later stages of pregnancy. However, none 
of the women interviewed suggested that the burden of 
travel had influenced their decision to attend ANC. Sev-
eral respondents explicitly stated that they felt it was 
important to attend ANC despite this challenge:
Researcher: Did the effort involved in travelling to 
the facility influence when and how often you visited 
a doctor or midwife for check-up?
Woman 18: No, because I felt I must take care of 
myself and the baby to ensure that both of us are 
healthy.
This suggests that distance to the point of care and 
lack of transport, which have been cited by studies con-
ducted in a range of African countries [18, 19] are not 
likely to act as barriers to repeated ANC attendance and 
IPTp uptake among women who generally attend ANC. 
The concerns over the burden of travel raised by some 
of the women interviewed who lived at a distance from 
the nearest health facility, though they did not keep the 
respondents from attending ANC, suggest that having to 
travel long distances may act as a disincentive for women 
who do not attend ANC at all.
Affordability
The majority of women and community leaders con-
firmed that all ANC services at public facilities were 
offered free of charge in line with government policy. 
However, several women in West Nile who attended 
ANC at public facilities reported they had been asked to 
pay a small fee when they first visited ANC or they had 
been required to pay for an ANC card:
Woman 14: I spend the money only for buying ante-
natal card. And I don’t know, but during my first 
visit they told me to pay 500 shillings.
While private for-profit facilities are expected to pro-
cure SP, the government has committed to providing SP 
free-of-charge to public facilities. It also provides funds 
to PNFP facilities to procure essential medicines, includ-
ing SP. However, this study found that stock-outs appear 
to persist in PNFP facilities [12]. Health workers at the 
PNFP facility included in the study sample indicated that 
they may charge women for the provision of IPTp or ask 
them to buy SP and bring it to the facility when they are 
experiencing stock-outs of the drug:
Researcher: Are women required to pay for the pro-
vision of IPTp at your facility?
Health worker 13: Yes.
Researcher: How much?
Health worker 13: One thousand Ugandan shillings 
when [we] buy [it] ourselves. Due to stock-out, we 
ask money from them at no profit, but they don’t pay 
when available.
It can therefore be assumed that women accessing 
ANC through private providers are likely to incur costs 
for the provision of IPTp, at least occasionally.
In addition to direct costs, several of the women inter-
viewed, in particular those who lived at a distance from 
the nearest health facility, referred to the indirect costs of 
visiting ANC, for example costs associated with travelling 
to the health centre or paying for accompanying relatives. 
The opportunity costs associated with ANC attendance 
were also occasionally mentioned:
Woman 6: And when you reach here [the health 
facility], you are tired and yet you have to go back 
and you won’t be able to do any work, so that means 
you have to over think whether to come.
This issue was also raised by a number of district health 
officials and health workers in West Nile, who specu-
lated that some women may not be able to attend ANC 
regularly because of what they perceived as cultural 
pressure on women to contribute towards their families’ 
livelihood:
District health official 6: So – and then our social 
works. Women – by the role of the culture here – 
women are exposed to too much work. So you find 
a pregnant mother – she’s busy in the garden and 
what. So she does not come for – to attend to the 
antenatal, where she can get this treatment.
About one third of the women interviewed stated that, 
overall, the costs associated with attending ANC were 
low and did not present a challenge to ANC attendance. 
However, the majority reported that given the wide-
spread poverty and lack of financial support from part-
ners and families, they found the financial burden of 
ANC attendance challenging:
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Researcher: Was it difficult to find the money to pay 
for the visit?
Woman 17: Yes and being the only child and no sup-
port from any one.
None of the women interviewed indicated that cost had 
affected their decision to attend, however. Several stated 
that they felt it was important to make use of the service 
despite the financial burden and described how they had 
to be resourceful and plan ahead in order to ensure the 
financial means were available when needed:
Woman 3: To get money I go to some garden to work 
and they give you from there [inaudible], then I come 
and go to the hospital. You have to estimate that – 
tomorrow I have to go, so you start today looking for 
where there is any casual work. If someone says that 
you come and help me and gives you money, tomor-
row you go to the hospital.
Both direct and indirect costs, real or perceived, have 
been discussed as barriers to uptake of ANC and IPTp in 
the literature [20, 21]. While the findings from this study 
suggests that affordability is not likely to be a major bar-
rier among those who generally attend ANC and those 
who attend in the public sector, the impact of user fees 
on women who do not attend ANC and those who attend 
at private sector facilities should be investigated in more 
detail. In general, user fees levied at private facilities have 
been associated with the emergence of an equity gap in 
terms of access to health care in Uganda, with the poor-
est unlikely to afford the services [22]. This is particularly 
relevant because of the considerable size of the private 
health care sector in the country [23].
Acceptability
Vulnerability and social support
Most women and all community leaders acknowledged 
that pregnant women are more vulnerable compared 
with non-pregnant adults. They mentioned a range of 
pregnancy-related health issues and emphasized that 
pregnant women need to adapt behaviour patterns due 
to their heightened vulnerability during pregnancy, for 
example eating a healthy diet and paying more atten-
tion to hygiene and cleanliness. Many reported that their 
partners, family and community leaders take a special 
interest in their wellbeing while they are pregnant.
However, several women complained that their part-
ners did not appreciate women’s heightened vulnerability 
during pregnancy:
Woman 15: If my husband forces me to do work and 
yet am sick, I cannot do the work as he wanted. He 
will even want to fight me that will now force me to 
go and explain to my brother-in-laws.
Researcher: Does he fight you while you are preg-
nant?
Woman 15: Yes.
Lack of emotional and practical support from part-
ners was also highlighted as a potential barrier for ANC 
attendance by a range of district health officials and 
health workers. However, while involving partners in 
ANC has been found to generally improve health ser-
vices for mother and child [24] and should therefore 
be encouraged, based on the findings from this study 
it appears unlikely that this will improve IPTp uptake 
among women who generally attend ANC.
Formal versus traditional care
All women and opinion leaders expressed very positive 
views with regard to seeking care from qualified provid-
ers, especially during pregnancy. Many emphasized the 
role of trust in health workers’ expertise:
Woman 1: In case there is something disturbing my 
health, I will go to visit a doctor to tell my problem 
and we share. After, he advises me on what to do. 
Thus I can get peace of mind. Because when I am 
at home, I can’t know what problem or disease that 
disturbs me. Thus I have to go to the hospital for test 
to determine the real problem.
Two district health officials in West Nile indicated 
that reservations with regard to formal care providers 
may persist in more remote communities. They specu-
lated that women may prefer to use the services of tra-
ditional birth attendants, possibly because they are more 
responsive to women’s needs. This was confirmed by two 
women in West Nile who reported that some of their 
peers preferred traditional medicine. However, several of 
the women interviewed expressed a clear preference for 
formal care:
Researcher: As an individual what do you know 
about the local medicine and what effects they have 
when taken?
Woman 18: The local medicines always have bad 
effects like causing abortion and even death and 
those giving them do not first examine you before 
administering it.
As several studies have shown preference for traditional 
care over formal health care in sub-Saharan Africa [25, 
26], the widespread preference for formal care reported 
in this study is an encouraging finding.
Taking medication
Most district health officials and health workers hypoth-
esized that pregnant women may not want to take 
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medication and may therefore refuse to take IPTp. How-
ever, all women and opinion leaders expressed gener-
ally positive attitudes towards taking medication if it 
is beneficial to the wellbeing of mother or child. Many 
explicitly mentioned receiving medication as a benefit 
of seeking care from a qualified provider, in particular 
women from Eastern region, where the term used to refer 
to ANC in the local language literally translates as ‘taking 
medication’:
Woman 6: The thing that made me come was to take 
medication. Because they call that ‘taking medica-
tion’.
Many women stated that while they were generally 
hesitant to take medication while pregnant, they trusted 
nurses’ and doctors’ judgement and expertise and were 
prepared to accept medication when recommended by a 
health worker:
Woman 16: Another one is not to use drugs unneces-
sary. If you are pregnant, you should use drug pre-
scribed to you in the health facility. Don’t buy drugs 
from the vendor and swallow like that.
Concerns over taking medication while pregnant have 
been discussed as a potential barrier to IPTp uptake in 
the literature [27]. However, it appears that most women 
can be persuaded to accept medication if the benefits are 
pointed out by a qualified health care provider. This con-
firms that women’s trust in health workers’ judgement 
plays a crucial role in ensuring high IPTp uptake, which 
has been highlighted by a number of previous studies 
[28–30].
Malaria and malaria prevention
District health officials and health workers frequently 
mentioned that pregnant women’s and communities’ 
lack of awareness of the risks of malaria in pregnancy 
was likely to be one of the main reasons behind the low 
uptake of IPTp. However, all opinion leaders and women 
interviewed showed some level of risk awareness. For 
example, the majority of women stated that pregnant 
women were more susceptible to malaria than non-preg-
nant women and most knew that malaria infection dur-
ing pregnancy can lead to miscarriage. Several women 
also knew that malaria in pregnancy can negatively affect 
the health of the child.
Women and opinion leaders generally agreed that 
it was important for pregnant women to take steps to 
avoid malaria infection. With one exception, all women 
reported sleeping under a mosquito net. Even though 
district health officials speculated that women may not 
believe that taking medication was an effective malaria 
prevention mechanism, all but one of the women 
interviewed were supportive of the idea of taking preven-
tive medication, particularly when prescribed by a health 
worker:
Woman 12: If the drugs are prescribed to you, then 
you have to accept, you should follow the instruc-
tions.
This suggests that lack of risk awareness, which has fre-
quently been cited as a barrier to IPTp uptake in the lit-
erature [31], does not contribute to missed opportunities 
for the provision of IPTp among women attending ANC, 
a finding supported by a study in Ghana, Kenya and 
Malawi, which concluded that a majority of women were 
aware of the risks of malaria in pregnancy [32]. It was evi-
dent, however, that many women and opinion leaders did 
not distinguish clearly between taking medication to pre-
vent malaria and taking medication to treat symptomatic 
malaria, a challenge which has also been reported from 
Malawi and Ghana [33].
Timing and frequency of ANC attendance
The most frequently cited challenge for repeated admin-
istration of IPTp by district health officials and health 
workers was that pregnant women tended to initiate 
ANC late during their pregnancy, which means there 
may not be sufficient time to provide more than the first 
dose of IPTp:
Health worker 2: Through experience some of our 
mothers just stay at home. And then come in the 
third trimester, so you find that there is no way you 
can fix a second dose. The mother will either take 
a first dose and deliver or the mother may come in 
labour.
Several district health officials and health workers 
in West Nile also stated that many pregnant women 
attended ANC infrequently, which would also lead to 
missed opportunities for the provision of repeated doses 
of IPTp:
District health official 7: Ok – about the IPTs I think 
[…] – you know mostly – mostly in Uganda, women 
just come for the first – first ANC. Ya. After first 
ANC, they sometimes disappear. They don’t come 
for the – the – those remaining one. So they miss the 
IPT.
Some respondents speculated that women may attend 
ANC late or infrequently because they fail to see the 
need for continuous services, particularly once the preg-
nancy has been confirmed as generally uncomplicated. 
Another possible reason cited for late attendance was 
that women may only attend ANC in order to receive 
an ANC card, which entitles them to receive care from 
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a skilled provider when they give birth. Only a few mid-
wives acknowledged that while late and infrequent ANC 
attendance was a challenge in principle, the majority of 
women attended ANC regularly.
By contrast, all women interviewed, including those 
who had not received a full course of IPTp, were frequent 
and regular ANC attenders. Of those who had given 
birth at the time of the interview, all had attended ANC 
at least twice and most had followed the recommended 
four-visit schedule. There was some variation with regard 
to when women had initiated ANC, but most reported 
that they had first attended ANC between the third and 
fifth month of gestation. Most of the women and opinion 
leaders interviewed knew that the recommended num-
ber of ANC visits during the course of a pregnancy is 
four. Only two, both in West Nile, were not aware of the 
recommended four-visit schedule. A number of women 
emphasized the role of midwives in encouraging preg-
nant women to attend ANC frequently and reminding 
them to complete the recommended ANC schedule.
Health workers’ perception of late and infrequent ANC 
attendance as the main barriers to IPTp uptake have been 
highlighted by a recent study in Mali [34]. While late 
attendance has been cited as a barrier to IPTp uptake in 
the literature [35, 36], it seems likely that this no longer 
plays a significant role. This research and several other 
recent studies did not find any evidence of late ANC 
attendance or a significant effect of the timing of ANC vis-
its on IPTp [37–39]. A study conducted in Uganda in 2008 
found that the median gestational age at first ANC visit 
was 5.7 months with the vast majority of pregnant women 
returning for subsequent visits, leaving plenty of opportu-
nities for the provision of at least two doses of IPTp [40].
Attitudes towards ANC
All women, including those who did not receive a full 
course of IPTp, and all opinion leaders interviewed, 
expressed generally positive views with regard to attend-
ing ANC. Many made general comments about the role 
of ANC visits in ensuring the health of both mother and 
unborn child and in detecting pregnancy-related compli-
cations. The most frequently mentioned specific service 
provided as part of ANC was checking the baby’s posi-
tion. Other benefits mentioned included receiving incen-
tives such as mosquito nets, health education and the 
opportunity to get tested for HIV and other diseases. 
Several women and opinion leaders referred to receiving 
IPTp as one of the main benefits of attending ANC.
District health officials and health workers, on the 
other hand, suspected that negative or indifferent atti-
tudes towards ANC persisted and played a role in women 
missing out on the provision of IPTp. Some speculated 
that this may be due to a generally defeatist attitude 
among women or a culturally motivated reluctance to 
disclose their pregnancy early. Several respondents sug-
gested that pregnancy may not be perceived as a health 
issue and women may not see the need to visit a health 
facility if they are not sick:
District health official 1: I think, eh, the women do – 
do not necessarily fall sick, so that one has in mind 
– I have to go in what? – The health unit. So for 
them, they take for granted – after all they are what? 
[They] are healthy, why do I need to go there?
Many of the issues raised by district officials and health 
workers have been discussed in the literature. For example, 
reluctance to reveal pregnancy early on has been reported 
in Mali [34] and a tendency to only seek help if sick has 
been described in Mozambique [41]. While this was not 
confirmed by any of the women interviewed in this study, 
it was noticeable that many women tended to talk about 
seeking care and treatment when they are experiencing 
symptoms of sickness rather than to prevent sickness. 
Similarly, four women reported that they had initiated 
ANC because they felt unwell and were concerned about 
the baby’s health. It is therefore possible that a lack of 
awareness of the preventive benefits of ANC and IPTp may 
act as a barrier among those who do not attend ANC at all.
Attitudes towards IPTp and SP
Women and opinion leaders were generally supportive of 
the concept of IPTp. The majority of women interviewed 
during the first round of data collection remembered 
that they had received and taken a drug called Fansidar® 
when they attended ANC. Some could not remember 
the name, but were able to describe the drug and knew 
that it was used to prevent malaria. Women interviewed 
during the second round of data collection because they 
had not received a full course of IPTp stated that they had 
not been offered IPTp by the health worker and that they 
would have accepted it, had it been offered to them.
Many women, including those who had not received a full 
course of IPTp, stated that IPTp was effective in preventing 
the effects of malaria in pregnancy on mother and child. 
While some of the statements with regard to the benefits of 
IPTp did not reflect accurate biomedical knowledge, they 
illustrate the generally positive views held by respondents:
Woman 8: It makes the baby healthy and when you 
give birth, the child will be good. But not the one with 
a big head, disabled – and not the child which has got 
funny looks. But you will give birth to a beautiful baby 
when you use this drug.
The very positive perceptions of IPTp and willingness 
to take SP when offered was confirmed by the majority of 
health workers:
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Health worker 3: Actually, they – in our health facil-
ity, they don’t refuse. They always take when we give 
them. They take.
Though none of the respondents expressed concerns 
over the safety of IPTp, all types of respondents suggested 
that fear of side effects may contribute to the low uptake:
District health official 6: I happened to be in one of 
the health centre IV and I happened to be in – inter-
acting in one of the community around. Basically, 
there is [inaudible], when I was interacting – the side 
effects of the drug, the Fansidar – see, when they take 
it, they find it difficult. That is one reason.
While most of the women interviewed had not experi-
enced unpleasant side effects (including the two women 
interviewed during the second round of data collection 
who had previously received the first dose of IPTp), five 
reported that they had felt dizzy or nauseous after taking 
the medication. Some also reported that they had heard 
complaints of side effects from friends and family:
Woman 1: Personally I have never seen any effect, 
but my sisters and other pregnant women have com-
plained of this drug. For example, some say it has 
given my body to itch, swelling, pain for so long. Oth-
ers say it makes me to vomit – dizziness is what I 
have heard.
There appeared to be a particular concern about taking 
SP on an empty stomach. This was widely reported by all 
types of respondents:
Health worker 6: The challenge I have is mostly on 
the mothers. Because most of them don’t – they feel 
like they should carry the drug home. That is one of 
the challenge and they say – they say we have not 
taken anything, as were coming to the health unit. 
That is where more of the challenge is.
Health workers mentioned a range of other complaints 
they had heard from women attending ANC, including 
the size and number of the tablets, the unpleasant smell 
and bitter taste of SP. However, several health workers 
also pointed out that women can generally be persuaded 
to accept IPTp despite their concerns:
Health worker 5: They don’t reject. They do it will-
ingly. You just tell them – because once they come 
in contact with you, you are now friends. They know 
that – that is nurse, that is a medical worker. So now 
if I refuse to take this, they know it has no harm to 
me or to myself.
The widespread positive views on IPTp and SP found 
in this research contradict frequent reports of negative 
perceptions including fear of side effects in the literature 
[42, 43]. Reluctance to take SP on an empty stomach has 
also been reported [37, 44], even though there is no evi-
dence suggesting a link between nausea and taking SP on 
an empty stomach. From this research it appears that, in 
analogy with general concerns over taking medication in 
pregnancy, women can generally be persuaded to accept 
IPTp when recommended by a health worker. This has 
also been reported from a study conducted in Ghana, 
Kenya and Malawi [33].
Conclusions
District health officials and health workers generally 
agreed that barriers relating to knowledge and attitudes 
towards ANC and IPTp among pregnant women and 
their communities accounted for many of the missed 
opportunities for the provision of IPTp. It was evident, 
however, that women and opinion leaders did not con-
firm district health officials’ and health workers’ sus-
picions. It is possible that district officials and health 
workers may have been inclined to ascribe low IPTp 
uptake to demand-side issues, rather than relating it to 
the supply side and hence their own work. Note that, in 
this study, it was not possible to include observation of 
interactions between health workers and women access-
ing ANC in order to triangulate the data obtained from 
interviews. Similarly, social desirability bias may have led 
some women and opinion leaders to express exclusively 
positive views of ANC and IPTp and not to elaborate on 
their concerns. However, there was no difference with 
regard to attitudes among women who were selected 
with the help of health workers and those selected by 
field researchers from ANC registers. There was also no 
substantial difference between women from the different 
regions and catchment areas included in the study, those 
who were pregnant at the time of the research and those 
who had given birth and between those living close to or 
far from the nearest health centre.
A potential limitation of the study is the fact that all 
women interviewed attended ANC regularly and the 
researchers found it challenging to identify women who 
had not received a full course of IPTp. It is therefore 
possible that the views of those identified may not fully 
reflect the reasons for late or infrequent ANC attendance 
and how this affects IPTp uptake. For example, some of 
the barriers discussed as challenges, but not ultimately 
reasons for non-attendance (such as burden of travel 
and financial burden of visiting ANC), may in fact play a 
greater role in deterring women from attending early or 
frequently than our data suggest.
As this research focused on barriers to IPTp uptake 
among women who attend ANC and deliberately 
excluded non-attenders of ANC, many of the barriers 
Page 12 of 14Rassi et al. Malar J  (2016) 15:530 
emphasized by district health officials and health workers 
and raised by many previous studies cited in the Results 
and discussion section (such as preference for traditional 
care or indifference towards preventive care) may act as 
significant barriers for those who do not attend ANC at 
all. However, our study did not intend to address these 
question. Similarly, this study intended to focus on pub-
lic and PNFP facilities and therefore the lack of responses 
from clients accessing private care has meant that some 
challenges that may be specific to the private sector could 
not be explored in-depth. This appears to be particularly 
pertinent with regard to the issue of user fees and how 
they affect uptake of ANC and IPTp.
The generally positive views held by women and opin-
ion leaders on ANC and IPTp, combined with the high 
ANC attendance figures, low refusal rates for IPTp and 
general trust in health workers’ judgement and advice, 
lead to the conclusion that, for those women who attend 
ANC, supply-side issues are likely to be more pertinent 
and to account for the majority of missed opportunities 
for the provision of IPTp. This is in line with a number of 
recent studies that have concluded that the main reason 
for not taking IPTp was not being offered the drug by the 
health worker [37, 44–47]. It has also been found that fre-
quent ANC visits do not ensure access to IPTp-SP where 
other barriers exist [7, 46].
It appears likely that most women can be persuaded to 
accept IPTp and to return for subsequent doses if they 
receive encouragement and relevant information from 
health workers, especially where women report feeling 
dizzy or nauseous after receiving IPTp or where women 
express concerns about taking SP on an empty stom-
ach. This suggests that greater impact on IPTp uptake 
could be achieved by intervening on the supply side (see 
Table 4 for a summary of the supply-side recommenda-
tions resulting from this study, including the document 
and record review [12]). However, the following actions 
should be considered by policy makers, implementers 
and researchers in order to strengthen demand-side use 
of ANC and acceptance of IPTp:
Affordability
  • Strengthen the supply chain of SP for private facili-
ties, reducing the likelihood of private facilities 
charging for IPTp or asking women to buy SP from 
pharmacies or drug vendors.
Acceptability
  • Educate health workers and district officials with 
regard to ANC and IPTp uptake data from household 
surveys and HMIS, as well as research highlighting 
generally positive attitudes among women and com-
munities to address the apparent misconception that 
demand-side barriers account for the majority of 
missed opportunities for the provision of IPTp.
  • Design behaviour change messages, for example 
those delivered as part of routine health talks at 
health facilities, around the distinction between pre-
vention and treatment, highlighting the preventive 
benefits of ANC and IPTp.
  • Alert health workers to the role of trust in the rela-
tionship with their clients and their role in encour-
Table 4 Recommendations from study findings relating to the supply side
Stakeholders and coordination Strengthen linkages between government and implementing partners
Encourage vertical integration of health programmes, e.g. malaria and maternal and child health
Policies and guidelines Ensure implementation of the most recent WHO policy recommendation of monthly IPTp administration after the first 
trimester
Clarify policy of encouraging male involvement in ANC, ensuring women attending without their partners are not 
disadvantaged
Provision of ANC services Ensure ANC is offered consistently in all health centres II, III, IV and hospitals as per national policy
Encourage professional behaviour among health workers to create a positive ANC experience for all clients
Provide incentives such as mosquito nets to encourage early and frequent ANC attendance
Supply chain Consider supplying SP free-of-charge to private health facilities
Capacity building Train health workers on malaria in pregnancy and IPTp to improve knowledge of the IPTp guidelines
Consider use of alternative, non-disruptive training methods
Provide guidance on differentiating between mild and severe side effects of SP and emphasize the importance of 
taking SP as directly observed therapy
Monitoring and evaluation Ensure supply of standard recording and reporting tools to health facilities
Ensure forms are designed to capture all plausible scenarios
Improve health workers’ data management skills and provide clear guidelines with regard to recording conventions
In addition to assessing completeness and timeliness of reported facility-level data, feedback should also be provided 
with regard to data accuracy
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aging women to follow the recommended four-visit 
ANC schedule. Empower midwives to provide 
encouragement to pregnant women who have con-
cerns over IPTp and SP to accept the medication, for 
example when women report having experienced 
mild side effects or do not want to take the drug on 
an empty stomach, insisting on providing IPTp as 
DOT at the health facility rather than letting women 
take the drug at home.
  • Conduct research with women who do not attend 
ANC to determine barriers to ANC uptake among 
this group.
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